Detalles de la búsqueda
1.
Effects of combination of mitiglinide with various oral antidiabetic drugs in streptozotocin-nicotinamide-induced type 2 diabetic rats and Zucker fatty rats.
Clin Exp Pharmacol Physiol
; 44(12): 1263-1271, 2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-28744906
2.
Comparison of the Effects of Mitiglinide and Glibenclamide Administered in Combination with the Dipeptidyl Peptidase-IV Inhibitor Sitagliptin in Rats with Streptozotocin-Nicotinamide-Induced Type 2 Diabetes.
Drug Res (Stuttg)
; 67(7): 396-403, 2017 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-28486736
3.
Effects of mitiglinide and sulfonylureas in isolated canine coronary arteries and perfused rat hearts.
Eur J Pharmacol
; 531(1-3): 194-200, 2006 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-16443212
4.
Sergliflozin etabonate, a selective SGLT2 inhibitor, improves glycemic control in streptozotocin-induced diabetic rats and Zucker fatty rats.
Eur J Pharmacol
; 609(1-3): 148-54, 2009 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-19281809
5.
[Pharmacological and clinical profile of mitiglinide calcium hydrate (Glufast), a new insulinotropic agent with rapid onset].
Nihon Yakurigaku Zasshi
; 124(4): 245-55, 2004 Oct.
Artículo
en Japonés
| MEDLINE | ID: mdl-15467258
6.
Effect of KAD-1229, a novel hypoglycaemic agent, on plasma glucose levels after meal load in type 2 diabetic rats.
Clin Exp Pharmacol Physiol
; 29(5-6): 423-7, 2002.
Artículo
en Inglés
| MEDLINE | ID: mdl-12010187
7.
Study of the insulinotropic effect of the novel antihyperglycemic agent KAD-1229 using HIT T15 cells, a hamster's insulinoma cell line.
Arzneimittelforschung
; 52(8): 605-9, 2002.
Artículo
en Inglés
| MEDLINE | ID: mdl-12236048
Resultados
1 -
7
de 7
1
Próxima >
>>